Pitch: a startup developing clinically validated prebiotic fibre blends designed to support gut, metabolic, immune and brain health.

Source: Myota

ID card

• HQ: UK
• Founded: 2019
• Funding: $5.3M
• Last Funding: $4.5M Series A (06/2026)
• Partnerships: SuanNutra (exclusive distribution partner for Europe, the UK and the US), Joe & The Juice (commercial launch of its prebiotic blend in functional smoothies)
• Innovations: Patented prebiotic fibre blends designed to maximise short-chain fatty acid (SCFA) production across diverse gut microbiomes
• Competitors: Supergut (US), Ora Biotics (Denmark)
• Regulation: Ø

More insights

• Its powder blends, supported by 4-week clinical trials, combine plant-based prebiotic fibres (oat and wheat fibres, guar fibre, inulin, fructooligosaccharides and galactooligosaccharides) with zinc to maximise SCFA production across diverse gut microbiomes.

• Its consumer portfolio includes:

  • a gut health prebiotic blend targeting bloating, abdominal pain and bowel regularity
  • a metabolic health blend designed to improve insulin sensitivity, reduce inflammation and lower blood glucose responses
  • high-fibre snack bars

Source: Myota

• The startup is expanding beyond D2C supplements into a B2B ingredients business for food, beverage and nutraceutical manufacturers, notably in Europe and the US.
• It is currently developing products with major dairy, bakery and functional beverage manufacturers.

For Symrise

Why did we select the startup?

Myota develops clinically validated prebiotic fibre blends that could support Symrise's innovation in gut, metabolic and functional wellness products, including GLP-1 companion formulations.

Why now?

Following its Series A, Myota is scaling its B2B ingredient business across Europe and the US, supported by collaborations with food manufacturers.

Source: Myota